Thanks, I accept the critique. I do think it’s clear from the full post, however, that I’m just making the case for greater focus by the community, rather than saying this is a closed case. I also state clearly in the same paragraph that other studies had much higher cost estimates.
Super interesting and thank you for sharing! A potential advantage of vaccination is that it does not require daily dosing (unlike hypertension medications), and of course, it has the benefit of also preventing illness. Would be interesting to see cost-effectiveness analyses for seasonal influenza campaigns.
Thanks for the link! I look forward to reading up on it.
Thanks for reading and for the support! I like suggestion of a prize, which could encourage some risk-taking but also orient investment towards an objectively defined goal. Another way to extend the model would be for more and more venture philanthropists to explicitly adopt this strategy of funding projects that push towards GiveWell listing, recognizing that this is their opportunity to “exit” (IE—move on to funding other promising projects).
Thanks for the support! Eager to learn more and will read your post on impact markets :)